Search research articles
Contact Us
Filters
Showing results (31-40 of 373) with videos related to
Page
of 38
Sort By:
Journal of Mathematical Biology
|
November 5, 2021
Reduction of a stochastic model of gene expression: Lagrangian dynamics gives access to basins of attraction as cell types and metastabilty
Elias Ventre, Thibault Espinasse, Charles-Edouard Bréhier, et al.
Antiviral Therapy
|
January 14, 2016
Systematic review to determine the prevalence of transmitted drug resistance mutations to rilpivirine in HIV-infected treatment-naive persons
Vincent Calvez, Anne-Genevieve Marcelin, Johan Vingerhoets, et al.
Plos One
|
April 5, 2013
Scoring methods for building genotypic scores: an application to didanosine resistance in a large derivation set
Allal Houssaini, Lambert Assoumou, Veronica Miller, et al.
AIDS (London, England)
|
December 24, 2013
The tyrosine kinase inhibitor Dasatinib blocks in-vitro HIV-1 production by primary CD4+ T cells from HIV-1 infected patients
Manuela Pogliaghi, Laura Papagno, Sidonie Lambert, et al.
Microbiology Spectrum
|
September 23, 2024
Comparison of the indirect immunofluorescence assay and a commercial ELISA to detect KSHV antibodies
Valentin Leducq, Léa Ben Said, Sophie Sayon, et al.
Scientific Reports
|
July 27, 2017
Characterization of a Propionibacterium acnes Surface Protein as a Fibrinogen-Binding Protein
Philippe A Grange, Joël Raingeaud, Willy Morelle, et al.
AIDS Research and Treatment
|
May 3, 2012
Investigation of Super Learner Methodology on HIV-1 Small Sample: Application on Jaguar Trial Data
Allal Houssaïni, Lambert Assoumou, Anne Geneviève Marcelin, et al.
AIDS (London, England)
|
April 18, 2003
High indinavir plasma concentrations in HIV-positive patients co-infected with hepatitis B or C virus treated with low doses of indinavir and ritonavir (400/100 mg twice a day) plus two nucleoside reverse transcriptase inhibitors
Philippe Bossi, Gilles Peytavin, Claire Lamotte, et al.
Antiviral Therapy
|
February 22, 2007
Impact of HIV-1 reverse transcriptase polymorphism at codons 211 and 228 on virological response to didanosine
Anne-Genevieve Marcelin, Philippe Flandre, Andre Furco, et al.
International Journal of Molecular Sciences
|
May 14, 2022
Characterization of a <i>Cutibacterium acnes</i> Camp Factor 1-Related Peptide as a New TLR-2 Modulator in In Vitro and Ex Vivo Models of Inflammation
Constance Mayslich, Philippe Alain Grange, Mathieu Castela, et al.
Page
of 38
Search research articles
Search
Showing results (31-40 of 373) with videos related to
Sort By:
Page
of 38
Journal of Mathematical Biology
|
November 5, 2021
Reduction of a stochastic model of gene expression: Lagrangian dynamics gives access to basins of attraction as cell types and metastabilty
Elias Ventre, Thibault Espinasse, Charles-Edouard Bréhier, et al.
Antiviral Therapy
|
January 14, 2016
Systematic review to determine the prevalence of transmitted drug resistance mutations to rilpivirine in HIV-infected treatment-naive persons
Vincent Calvez, Anne-Genevieve Marcelin, Johan Vingerhoets, et al.
Plos One
|
April 5, 2013
Scoring methods for building genotypic scores: an application to didanosine resistance in a large derivation set
Allal Houssaini, Lambert Assoumou, Veronica Miller, et al.
AIDS (London, England)
|
December 24, 2013
The tyrosine kinase inhibitor Dasatinib blocks in-vitro HIV-1 production by primary CD4+ T cells from HIV-1 infected patients
Manuela Pogliaghi, Laura Papagno, Sidonie Lambert, et al.
Microbiology Spectrum
|
September 23, 2024
Comparison of the indirect immunofluorescence assay and a commercial ELISA to detect KSHV antibodies
Valentin Leducq, Léa Ben Said, Sophie Sayon, et al.
Scientific Reports
|
July 27, 2017
Characterization of a Propionibacterium acnes Surface Protein as a Fibrinogen-Binding Protein
Philippe A Grange, Joël Raingeaud, Willy Morelle, et al.
AIDS Research and Treatment
|
May 3, 2012
Investigation of Super Learner Methodology on HIV-1 Small Sample: Application on Jaguar Trial Data
Allal Houssaïni, Lambert Assoumou, Anne Geneviève Marcelin, et al.
AIDS (London, England)
|
April 18, 2003
High indinavir plasma concentrations in HIV-positive patients co-infected with hepatitis B or C virus treated with low doses of indinavir and ritonavir (400/100 mg twice a day) plus two nucleoside reverse transcriptase inhibitors
Philippe Bossi, Gilles Peytavin, Claire Lamotte, et al.
Antiviral Therapy
|
February 22, 2007
Impact of HIV-1 reverse transcriptase polymorphism at codons 211 and 228 on virological response to didanosine
Anne-Genevieve Marcelin, Philippe Flandre, Andre Furco, et al.
International Journal of Molecular Sciences
|
May 14, 2022
Characterization of a <i>Cutibacterium acnes</i> Camp Factor 1-Related Peptide as a New TLR-2 Modulator in In Vitro and Ex Vivo Models of Inflammation
Constance Mayslich, Philippe Alain Grange, Mathieu Castela, et al.
Page
of 38